First-line nivolumab in stage IV or recurrent non-small-cell lung cancer

CheckMate 026, Alessandro Morabito

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First-line nivolumab in stage IV or recurrent non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences